Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 24, Issue 2, 2007, Pages 134-140

  Manika, Katerina ^a   Alexiou Daniel, Stella ^a   Papakosta, Despina ^a,b   Papa, Anna ^a   Kontakiotis, Theodore ^a   Patakas, Dimitrios ^a   Antoniadis, Antonis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki ^*  (Greece)

Author keywords

Epstein Barr virus; Idiopathic pulmonary fibrosis; Interstitial lung diseases

Indexed keywords

ANTIBODY; ANTIGEN; IMMUNOGLOBULIN A; VIRUS CAPSID ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA VIRUS; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTERSTITIAL LUNG DISEASE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; VIRUS CAPSID;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; PULMONARY FIBROSIS;

EID: 41149143131     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. American Thoracic Society, European Respiratory Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-64.
2. Coultas DB, Zumwalt RE, Black WC, Soboya RE: The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-72.
3. Scott J, Johnston I, Britton J: What causes cryptogenic fibrising alveolitis? A case-control study of environmental exposure to dust. Br Med J 1990; 301: 1015-7.
4. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldrom JA: Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155: 242-5.
5. Egan JJ, Woodcock AA, Stewart JP: Viruses and idiopathic pulmonary fibrosis. Eur Respir J 1997;10: 1433-7.
6. Rickinson AB, Kieff E: Epstein-barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. Lippinkott-Raven, New York, 1996; pp. 2397-2446.
7. Liebow AA, Canrington CD: Diffuse pulmonary lymphoreticular infiltrations associated with dysoproteinemia. Med Clin North Am 1973; 57: 809-43.
8. Vergnon JM, de Thé G, Weynants P, Vincent M, Mornex JF, Brune J: Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association? Lancet 1984; 6: 768-71.
9. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB, Woodcock AA: Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995; 50: 1234-9.
10. Stewart JP, Egan JJ, Ross AJ, et al: The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1999; 159: 1336-41.
11. Tang YW, Johnston JE, Browning PJ, et al: Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol 2003; 41: 2633-40.
12. Chuang HC, Lay JD, Chuang SE, Hsieh WC, Chang Y, Su U: Epstein-Barr Virus (EBV) Latent Membrane Protein-1 Down-Regulates Tumor Necrosis Factor-{alpha} (TNF-{alpha}) Receptor-1 and Confers Resistance to TNF-{alpha}-Induced Apoptosis in T Cells: Implication for the Progression to T-Cell Lymphoma in EBV-Associated Hemophagocytic Syndrome. Am J Pathol 2007; 170 (5): 1607-17.
13. Tsukamoto K, Hayakawa H, Sato A, Chida K, Nakamura H, Miura K: Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 2000; 55: 958-61.
14. Boivin G, Olson CA, Quirk MR, Kringstad B, Hertz MI, Jordan MC: Quantitation of CMV DNA and characterization of viral gene expression in BAL cells of infected patients with and without pneumonitis. J Infect Dis 1996; 173: 1304-12.
15. Wockel W, Hofler G, Popper HH, Marresi A: Lymphoepithelioma-like carcinoma of the lung. Path Res Pract 1995; 191: 1170-4.
16. Pfleger A, Eber E, Popper H, Zach MS: Chronic interstitial lung disease due to Epstein-Barr virus infection in two infants. Eur Respir J 2000; 15: 803-6.
17. Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypothesis about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134: 136-51.
18. Kelly BG, Lok SS, Hasleton PS, Egan JJ, Stewart JP: A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166: 510-3.
19. Li HP, Chang YS: Epstein-Barr virus latent protein 1: structure and functions. J Biomed Sci 2003; 10: 490-504.
20. Wakisaka N, Pagano JS: Epstein-Barr virus induces invasion and metastasis factors. Anticancer Res 2003; 23 (3A): 2133-8.
21. Takada K, Nanbo A: The role of EBERs in oncogenesis. Semin Cancer Biol 2001; 11 (6): 461-7.
22. Raghu G, Mageto YN, Lockhart D, Shmidt RA, Wood DE, Godwin L: The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 1999; 116: 1168-74.
23. Hunninghake GW, Zimmerman MB, Schwartz DA, et al: Utility of a biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164: 193-6.
24. Katzenstein ALA, Myers JL: Idiopathic pulmonary fibrosis: To biopsy or not to biopsy. Am J Respir Crit Care Med 2001; 164: 185-6.
25. Coultas DB, Zumwalt RE, Black WC, Soboya RE: The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-72.
26. Glaser R, Strain EC, Tarr KL, et al: Changes in Epstein-Barr virus antibody titers associated with aging. Proc Soc Exp Biol Med 1985; 179: 352-5.
27. Yomenaru M, Kasuga I, Kusumoto H, et al: Elevation of antibodies to CMV and other herpes viruses in pulmonary fibrosis. Eur Respir J 1997; 10: 2040-5.
28. Buljevac D, van Doornum GJ, Flach HZ, et al: Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 1377-81.
29. Tiwawech D, Srivatanakul P, Karaluk A, Ishida T: Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma. Asian Pac J Cancer Prev 2003; 4: 113-8.
30. Costabel U: Atlas der bronchoalveolräen lavage. Georg Thieme Verlag, Stuttgart; 1994.